Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Seminars in Oncology|March 3, 1998
Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changesJ Licinio, M A Kling, P HauserThe Journal of Pharmacy and Pharmacology|June 1, 1978
Rat brain and serum lithium concentrations after acute injections of lithium carbonate and orotateM A Kling, P Manowitz, I W PollackPsychoneuroendocrinology|June 7, 2000
Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disordersW T Regenold, M A Kling, P HauserThe American Journal of Psychiatry|September 1, 1987
Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulationJ R Calabrese, M A Kling, P W GoldBiological Psychiatry|April 1, 1993
Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteersM D De Bellis, T D Geracioti, M Altemus, et al.Seminars in Oncology|March 3, 1998
Mood and cognitive side effects of interferon-alpha therapyA D Valentine, C A Meyers, M A Kling, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 21, 2006
Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American womenM I Tolea, S A Black, O D Carter-Pokras, et al.The Psychiatric Clinics of North America|June 1, 1988
Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorderP W Gold, T A Pigott, M A Kling, et al.Psychiatry Research|February 1, 1994
CSF magnesium in affective disorder: lack of correlation with clinical course of treatmentM S George, D Rosenstein, D R Rubinow, et al.Synapse (New York, N.Y.)|July 1, 1991
Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniquesS Caldecott-Hazard, B H Guze, M A Kling, et al.Pageof 6